EBS
Income statement / Annual
Last year (2024), Emergent BioSolutions Inc.'s total revenue was $1.04 B,
a decrease of 0.54% from the previous year.
In 2024, Emergent BioSolutions Inc.'s net income was -$190.60 M.
See Emergent BioSolutions Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$1.04 B |
$1.05 B |
$1.12 B |
$1.77 B |
$1.58 B |
$1.11 B |
$782.40 M |
$560.90 M |
$488.80 M |
$489.33 M |
| Cost of Revenue |
$668.20 M
|
$689.30 M
|
$644.50 M
|
$980.40 M
|
$714.20 M
|
$622.90 M
|
$462.00 M
|
$277.30 M
|
$244.00 M
|
$216.85 M
|
| Gross Profit |
$375.40 M
|
$360.00 M
|
$473.00 M
|
$793.20 M
|
$863.10 M
|
$483.10 M
|
$320.40 M
|
$283.60 M
|
$244.80 M
|
$272.49 M
|
| Gross Profit Ratio |
0.36
|
0.34
|
0.42
|
0.45
|
0.55
|
0.44
|
0.41
|
0.51
|
0.5
|
0.56
|
| Research and Development Expenses |
$70.70 M
|
$111.40 M
|
$188.30 M
|
$235.20 M
|
$237.90 M
|
$226.20 M
|
$142.80 M
|
$97.40 M
|
$106.90 M
|
$119.19 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$202.50 M
|
$143.50 M
|
$143.69 M
|
$148.46 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$298.70 M
|
$356.70 M
|
$339.50 M
|
$348.70 M
|
$304.10 M
|
$273.50 M
|
$202.50 M
|
$142.90 M
|
$143.10 M
|
$121.15 M
|
| Other Expenses |
$114.70 M
|
$618.30 M
|
$115.20 M
|
-$132.10 M
|
-$117.40 M
|
-$130.70 M
|
-$114.70 M
|
-$81.00 M
|
-$110.70 M
|
-$109.36 M
|
| Operating Expenses |
$484.10 M
|
$1.09 B
|
$643.00 M
|
$451.80 M
|
$424.60 M
|
$369.00 M
|
$230.60 M
|
$159.30 M
|
$139.30 M
|
$130.97 M
|
| Cost And Expenses |
$1.15 B
|
$1.78 B
|
$1.29 B
|
$1.43 B
|
$1.14 B
|
$991.90 M
|
$692.60 M
|
$436.60 M
|
$383.30 M
|
$347.82 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$1.75 M
|
$1.05 M
|
$572.00 K
|
| Interest Expense |
$71.00 M
|
$87.90 M
|
$37.30 M
|
$34.50 M
|
$31.30 M
|
$38.40 M
|
$9.90 M
|
$6.59 M
|
$7.62 M
|
$6.52 M
|
| Depreciation & Amortization |
$105.60 M
|
$121.10 M
|
$125.00 M
|
$118.20 M
|
$110.00 M
|
$108.00 M
|
$62.20 M
|
$42.60 M
|
$38.20 M
|
$35.34 M
|
| EBITDA |
$53.40 M |
-$47.00 M |
$15.70 M |
$504.20 M |
$609.20 M |
$258.90 M |
$155.10 M |
$174.70 M |
$132.90 M |
$186.68 M |
| EBITDA Ratio |
0.05
|
-0.04
|
0.01
|
0.28
|
0.39
|
0.23
|
0.2
|
0.31
|
0.27
|
0.38
|
| Operating Income Ratio |
-0.1
|
-0.69
|
-0.15
|
0.19
|
0.28
|
0.1
|
0.11
|
0.22
|
0.22
|
0.29
|
| Total Other Income/Expenses Net |
-$34.20 M
|
-$4.80 M
|
-$49.00 M
|
-$38.20 M
|
-$26.60 M
|
-$36.70 M
|
-$8.30 M
|
-$5.70 M
|
-$6.30 M
|
-$5.80 M
|
| Income Before Tax |
-$142.90 M
|
-$731.20 M
|
-$219.00 M
|
$303.20 M
|
$411.90 M
|
$77.40 M
|
$81.50 M
|
$118.60 M
|
$99.20 M
|
$135.72 M
|
| Income Before Tax Ratio |
-0.14
|
-0.7
|
-0.2
|
0.17
|
0.26
|
0.07
|
0.1
|
0.21
|
0.2
|
0.28
|
| Income Tax Expense |
$47.70 M
|
$29.30 M
|
-$7.40 M
|
$83.70 M
|
$106.10 M
|
$22.90 M
|
$18.80 M
|
$36.00 M
|
$36.70 M
|
$44.30 M
|
| Net Income |
-$190.60 M
|
-$760.50 M
|
-$211.60 M
|
$219.50 M
|
$305.80 M
|
$54.50 M
|
$62.70 M
|
$82.60 M
|
$51.80 M
|
$62.87 M
|
| Net Income Ratio |
-0.18
|
-0.72
|
-0.19
|
0.12
|
0.19
|
0.05
|
0.08
|
0.15
|
0.11
|
0.13
|
| EPS |
-3.6 |
-14.85 |
-4.47 |
4.1 |
5.79 |
1.06 |
1.25 |
1.98 |
1.29 |
1.63 |
| EPS Diluted |
-3.6 |
-14.85 |
-4.47 |
4.06 |
5.67 |
1.04 |
1.22 |
1.71 |
1.13 |
1.41 |
| Weighted Average Shares Out |
$53.00 M
|
$51.20 M
|
$50.10 M
|
$53.50 M
|
$52.70 M
|
$51.50 M
|
$50.10 M
|
$41.82 M
|
$40.18 M
|
$38.60 M
|
| Weighted Average Shares Out Diluted |
$53.00 M
|
$51.20 M
|
$50.10 M
|
$54.10 M
|
$53.80 M
|
$52.40 M
|
$51.40 M
|
$50.33 M
|
$49.34 M
|
$47.26 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
